Abstract:Background: Chronic kidney disease (CKD) and heart failure (HF) are interrelated conditions that exacerbate each other through mechanisms like fluid retention, neurohormonal activation, and inflammation. Red blood cell distribution width (RDW), a measure of red blood cell size variability, has emerged as a potential prognostic marker in HF. This study aimed to assess the prognostic value of RDW in HF patients, both with and without CKD, focusing on all-cause mortality and HF rehospitalizations. Methods: This observational retrospective study included 171 patients hospitalized for acute decompensated HF in a tertiary university hospital in Greece. Patients were divided into two groups based on their estimated glomerular filtration rate (eGFR), as Group 1 (eGFR < 60 mL/min/1.73 m2) and Group 2 (eGFR ≥ 60 mL/min/1.73 m2). RDW was measured upon admission, and outcomes of interest were all-cause mortality and HF rehospitalizations over a median follow-up period of 6.1 months. Statistical analyses included Kaplan–Meier survival curves, whereas the discrimination traits of RDW were evaluated by constructing receiver operating characteristic (ROC) curves and by calculating the area under the ROC curve (AUC). A p-value <0.05 was indicative of a statistically important result. Results: Patients in Group 1 (eGFR < 60 mL/min/1.73 m2) were older (80 (73–86) vs. 75 (62–83)) and manifested higher median RDW values (16.6 (15.0–18.8) vs. 15.6 (14.1–17.8)) and received less frequent (57.9% vs. 75%) mineralocorticoid receptor antagonists (MRAs) as compared to those in Group 2 (eGFR ≥ 60 mL/min/1.73 m2). RDW demonstrated better prognostic value in predicting combined mortality and rehospitalization outcomes in Group 2 patients (area under the curve: 0.70; 95% CI (0.62–0.80)) compared to those in Group 1 (area under the curve: 0.53; 95% CI (0.35–0.72)). No statistically significant differences (p = 0.579) were observed in survival between patients with high (≥15%) and low (<15%) RDW values in the overall population, though trends favored worse outcomes with elevated RDW. Similarly, no significant differences (p = 0.374) were observed in survival between patients with high (Group 2) and low (Group 1) eGFR values. Conclusions: RDW appears to be a meaningful prognostic biomarker for HF patients, particularly in those without CKD. Further multicenter studies are needed to validate its clinical utility and potential for guiding treatment in this high-risk population.

The Prognostic Value of Red Blood Cell Distribution Width in Patients on Maintenance Hemodialysis.

Red Cell Distribution Width: A Novel Predictor of Mortality in Critically Ill Patients

Red Cell Distribution Width is Associated with Hospital Mortality in Unselected Critically Ill Patients.

Status of Red Blood Cell Distribution Width in Hemodialysis Patients and the Related Factors

Prognostic Value Of Red Blood Cell Distribution Width In Non-Cardiovascular Critically Or Acutely Patients: A Systematic Review

Red Blood Cell Distribution Width is an Independent Predictor of AKI and Mortality in Patients in the Coronary Care Unit

Red blood cell distribution width and mortality risk in critically ill cardiovascular patients

Impact of Red Cell Distribution Width on Outcome of 16 681 Patients with Chronic Systolic Heart Failure

Association between red blood cell distribution width and long-term mortality in acute respiratory failure patients

Platelet Distribution Width and Mortality in Hemodialysis Patients

Red Blood Cell Distribution Width is Associated with Adverse Kidney Outcomes in Patients with Chronic Kidney Disease

Red Cell Distribution Width is Associated with Short‐term Mortality in Critically Ill Patients with Heart Failure

Red blood cell distribution width-derived indces predicts long-term prognosis in acute heart failure

Red blood cell distribution width as a marker of cerebral infarction in hemodialysis patients

Red cell distribution width associations with clinical outcomes: A population-based cohort study

Prognostic Value of Red Blood Cell Distribution Width for Patients with Heart Failure: a Systematic Review and Meta-Analysis of Cohort Studies.

Red Cell Distribution Width As an Independent Predictor of Long-Term Mortality in Hip Fracture Patients: A Prospective Cohort Study.

Differences in the Predictive Value of Red Cell Distribution Width for the Mortality of Patients with Heart Failure Due to Various Heart Diseases

The Prognostic Role of RDW in Hospitalized Heart Failure Patients with and Without Chronic Kidney Disease

Red cell distribution width predicts short- and long-term outcomes of acute congestive heart failure more effectively than hemoglobin

Relationship between red blood cell distribution width with non-invasive hemodynamic monitoring and body composition in peritoneal dialysis patients